Making

Last week, drug giant Pfizer told investors that it expects to make more than $50 billion off its COVID-19 medicines this year. Its vaccine is the most lucrative medicine in history, accruing $37 billion in 2021, and has sent its corporate revenues into the stratosphere. By the end of this year, […]